Smartphone help to prevent relapse in opioid use disorder
Part of Mental health clinical trials.
This study looks at whether a smartphone-based program can help people avoid relapse from opioid use disorder. Some participants may also do brain scans to better understand the brain changes behind relapse prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You are currently in “Phase I” medication treatment for opioid-use disorder (limited take-home doses)
- If you are assigned to the smartphone group, you are willing to use a smartphone
- For the brain-scan part: you are age 18 to 50 and speak English as your native language
- For the brain-scan part: you can safely do MRI (no metal/unsafe implants, no severe claustrophobia, and you can tolerate loud noise)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smartphone app to support Veterans in their recovery from opioid use disorder. The app aims to improve daily functioning alongside medication treatment.
This study uses brain scans to understand how methadone or buprenorphine treatment affects the brain, with the goal of helping people stay in treatment and avoid relapse. You would need to be recently started on one of these medications and be able to undergo MRI scans.
This Phase 3 study tests whether using smartphones can help people with opioid-use disorder stick with treatment and recover more successfully. It focuses on people starting or already in treatment using methadone or buprenorphine, with support delivered through the study app or messages.
This study is testing a smartphone app to help people who are starting or restarting medication for opioid use disorder. If you join, you'll use the app to support your recovery journey.
This study tests if a mobile mindfulness training app can help people who are receiving medication treatment for opioid use disorder. It is for people with a history of childhood trauma who are stable on their medication.
This study tests a brief smartphone-based program to help people reduce heavy drinking while they are receiving medication for opioid use disorder (MOUD). It aims to improve both alcohol and mental health outcomes.
Hear when a new Opioid-Related Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.